Haemonetics Corporation Income (Loss) from Continuing Operations before Income Taxes, Domestic
Haemonetics Corporation (HAE) reported Income (Loss) from Continuing Operations before Income Taxes, Domestic of $87.24 million for the 12-month period ending 2026-03-28, per its 10-K filed 2026-05-20.
Financial Statements › Income Statement › Pre-tax Income
us-gaap:IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic · last filed 2026-05-20
- Haemonetics Corporation income (loss) from continuing operations before income taxes, domestic for fiscal 2026 was $87.24M, a 46.08% decline from fiscal 2025.
- Haemonetics Corporation income (loss) from continuing operations before income taxes, domestic for fiscal 2025 was $161.80M, a 43.74% increase from fiscal 2024.
- Haemonetics Corporation income (loss) from continuing operations before income taxes, domestic for fiscal 2024 was $112.56M, a 31.41% increase from fiscal 2023.
- Haemonetics Corporation income (loss) from continuing operations before income taxes, domestic for fiscal 2023 was $85.66M.
| Period end | Income (Loss) from Continuing Operations before Income Taxes, Domestic 12 month |
|---|---|
| 2026-03-28 | $87.24M 10-K · filed 2026-05-20 |
| 2025-03-29 | $161.80M 10-K · filed 2026-05-20 |
| 2024-03-30 | $112.56M 10-K · filed 2026-05-20 |
| 2023-04-01 | $85.66M 10-K · filed 2025-05-21 |
| 2022-04-02 | -$5.22M 10-K · filed 2024-05-20 |
| 2021-04-03 | $5.53M 10-K · filed 2023-05-22 |
| 2020-03-28 | $5.34M 10-K · filed 2022-05-25 |
| 2019-03-30 | $26.66M 10-K · filed 2021-05-26 |
| 2018-03-31 | $3.53M 10-K · filed 2020-05-20 |
| 2017-04-01 | -$44.72M 10-K · filed 2019-05-22 |
| 2016-04-02 | -$18.53M 10-K · filed 2018-05-23 |
| 2015-03-28 | -$17.27M 10-K · filed 2017-05-24 |
| 2014-03-29 | -$6.86M 10-K · filed 2016-06-01 |
| 2013-03-30 | $17.36M 10-K · filed 2015-05-22 |
| 2012-03-31 | $40.67M 10-K · filed 2014-05-22 |
| 2011-04-02 | $58.04M 10-K · filed 2013-05-20 |
| 2010-04-03 | $42.26M 10-K · filed 2012-05-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| TELEFLEX INC (TFX) | United States | $5.093B | -5.44 |
| MERIT MEDICAL SYSTEMS INC (MMSI) | United States | $5.212B | 28.44 |
| Heartflow, Inc. (HTFL) | United States | $4.225B | |
| ICU MEDICAL INC/DE (ICUI) | United States | $4.153B | 18.85 |
| MiniMed Group, Inc. (MMED) | United States | $5.748B | -16.85 |
| PULSE BIOSCIENCES, INC. (PLSE) | United States | $3.696B | -24.47 |
| iRhythm Holdings, Inc. (IRTC) | United States | $3.651B | -281.06 |
| AtriCure, Inc. (ATRC) | United States | $3.089B | |
| UFP TECHNOLOGIES INC (UFPT) | United States | $2.308B | 28.37 |
| Inspire Medical Systems, Inc. (INSP) | United States | $1.990B | 9.55 |